Description

 

Millipore's new ArthroMAB™ Monoclonal Antibody Cocktail is widely used to generate arthritis mouse models. These models are used for rapid screening and evaluation of anti-inflammatory therapeutics.

ArthroMAB™ initiates arthritis via immune complex formation on the surface of cartilage in joints.

ArthroMAB™ is a cocktail of four monoclonal antibodies directed against Collagen. It rapidly induces robust arthritis in all four paws of a variety of mouse strains (e.g., Balb/C–CIA resistant, DBA/1, B10.RIII). Compared to the traditional collagen induced arthritis (CIA) model, the ArthroMAB™ kit (which includes antibody cocktail and bacterial lipopolysaccharide (LPS), induces severe arthritis in mice within days instead of weeks and allows researchers to test far fewer animals since the incidence of arthritis is nearly 100%. Furthermore, synchronized disease onset between mice reduces treatment schedules and simplifies assessment studies, when compared to other arthritis models.

Feedback

Request info

To:EMD Millipore, a division of Merck KGaA, Darmstadt, Germany
From:
Please contact me / call me with the ArthroMAB™ Monoclonal Antibody Cocktail,

I am looking to purchase in /

.
About you

Write a review

Sharing your experience will help scientists like you. Achieve Reviewer Status and Win an iPad 3 (All reviews published will be entered into the next drawing on May 31st 2013).

  
Your Email

 



Ease of use

After sales services

Value for money

WATCH:
The benefits of becoming a reviewer
Share your opinions...()
HINTS & TIPS
Give reasons for the star ratings you have awarded for each area.
Would you recommend this to a colleague?
What would you like to have known about equipment and consumables before you purchased?



Join 200,000 Scientists Online

Become a member for FREE access to:

  • 250,000 full product and supplier listings
  • 10,000 user reviews and comments
  • Daily news and videos
  • 2,500 application notes and videos
  • 2,000 of the best jobs in Science

Don't miss out!

Join The Community Today